nach oben

Breast Cancer Research and Treatment

Erschienen in:

20.04.2020 | Review

Evaluation and management of insomnia in women with breast cancer

verfasst von: Agnes Kwak, Jamie Jacobs, Dana Haggett, Rachel Jimenez, Jeffrey Peppercorn

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Insomnia is a common issue among patients with breast cancer with a potentially devastating impact on quality of life. It can be caused or exacerbated by multiple disease and treatment-related factors. Despite the prevalence and impact of insomnia, it is rarely addressed systematically in the oncology clinic. We conducted a comprehensive review of insomnia to guide clinical care of patient’s with breast cancer and insomnia.

Methods

This manuscript reviews the prevalence, etiology, emerging science and both non-pharmacologic and pharmacologic options for treatment of insomnia among patients with breast cancer.

Results

Multiple factors contribute to insomnia among patients with breast cancer including endocrine therapy and hotflashes, pain and discomfort from local therapy, and fear of recurrence. If we do identify insomnia, there are treatment options and strategies available to help patients. In particular, there is now a considerable body of evidence supporting the use of psychosocial interventions and behavioral treatments, such as cognitive behavioral therapy for insomnia (CBT-I), yoga, and mind-body programs. It is also important for oncology providers to be educated regarding available pharmacologic therapies and emerging data for cannabis-based therapy.

Conclusion

This manuscript provides an up-to-date and comprehensive review of the prevalence, etiology, and treatment approaches available for insomnia for clinicians treating patients with breast cancer. We also address strategies and goals for cancer care delivery and future research.

American Psychiatric Association (2013) In: Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Association, Washington, DC

Zhou ES, Partridge AH, Syrjala KL, Michaud AL, Recklitis CJ (2017) Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv 11(1):74–79PubMed

Davidson JR, MacLean AW, Brundage MD, Schulze K (2002) Sleep disturbance in cancer patients. Soc Sci Med 54(9):1309–1321PubMed

Savard J, Simard S, Blanchet J, Ivers H, Morin CM (2001) Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 24(5):583–590PubMed

Kyle SD, Morgan K, Espie CA (2010) Insomnia and health-related quality of life. Sleep Med Rev 14(1):69–82PubMed

Bolge SC, Doan JF, Kannan H, Baran RW (2009) Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 18(4):415–422PubMed

Sarsour K, Kalsekar A, Swindle R, Foley K, Walsh JK (2011) The association between insomnia severity and healthcare and productivity costs in a health plan sample. Sleep 34(4):443–450PubMedPubMedCentral

Klink ME, Quan SF, Kaltenborn WT, Lebowitz MD (1992) Risk factors associated with complaints of insomnia in a general adult population Influence of previous complaints of insomnia. Arch Intern Med 152(8):1634–1637PubMed

Schieber K, Niecke A, Geiser F, Erim Y, Bergelt C, Buttner-Teleaga A, Maatouk I, Stein B, Teufel M, Wickert M et al (2019) The course of cancer-related insomnia: don't expect it to disappear after cancer treatment. Sleep Med 58:107–113PubMed

10.

Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH (2002) Sleep and quality of life in breast cancer patients. J Pain Symptom Manag 24(5):471–480

11.

Koopman C, Nouriani B, Erickson V, Anupindi R, Butler LD, Bachmann MH, Sephton SE, Spiegel D (2002) Sleep disturbances in women with metastatic breast cancer. Breast J 8(6):362–370PubMed

12.

Desai K, Mao JJ, Su I, Demichele A, Li Q, Xie SX, Gehrman PR (2013) Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors. Support Care Cancer 21(1):43–51PubMed

13.

Couzi RJ, Helzlsouer KJ, Fetting JH (1995) Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 13(11):2737–2744PubMed

14.

Savard J, Davidson JR, Ivers H, Quesnel C, Rioux D, Dupere V, Lasnier M, Simard S, Morin CM (2004) The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manag 27(6):513–522

15.

Cho NY, Kim S, Nowakowski S, Shin C, Suh S (2019) Sleep disturbance in women who undergo surgical menopause compared with women who experience natural menopause. Menopause 26(4):357–364PubMed

16.

Hatcher KM, Royston SE, Mahoney MM (2018) Modulation of circadian rhythms through estrogen receptor signaling. Eur J Neurosci 51:217PubMed

17.

Van Onselen C, Aouizerat BE, Dunn LB, Paul SM, West C, Hamolsky D, Lee K, Melisko M, Neuhaus J, Miaskowski C (2013) Differences in sleep disturbance, fatigue and energy levels between women with and without breast pain prior to breast cancer surgery. Breast 22(3):273–276PubMed

18.

Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19(3):895–908PubMed

19.

Palesh OG, Collie K, Batiuchok D, Tilston J, Koopman C, Perlis ML, Butler LD, Carlson R, Spiegel D (2007) A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 75(1):37–44PubMed

20.

Hall DL, Jimenez RB, Perez GK, Rabin J, Quain K, Yeh GY, Park ER, Peppercorn JM (2019) Fear of cancer recurrence: a model examination of physical symptoms, emotional distress, and health behavior change. J Oncol Pract 15(9):e787–e797PubMed

21.

Berrett-Abebe J, Cadet T, Pirl W, Lennes I (2015) Exploring the relationship between fear of cancer recurrence and sleep quality in cancer survivors. J Psychosoc Oncol 33(3):297–309PubMed

22.

Salo P, Sivertsen B, Oksanen T, Sjosten N, Pentti J, Virtanen M, Kivimaki M, Vahtera J (2012) Insomnia symptoms as a predictor of incident treatment for depression: prospective cohort study of 40,791 men and women. Sleep Med 13(3):278–284PubMed

23.

Siefert ML, Hong F, Valcarce B, Berry DL (2014) Patient and clinician communication of self-reported insomnia during ambulatory cancer care clinic visits. Cancer Nurs 37(2):E51–59PubMedPubMedCentral

24.

Engstrom CA, Strohl RA, Rose L, Lewandowski L, Stefanek ME (1999) Sleep alterations in cancer patients. Cancer Nurs 22(2):143–148PubMed

25.

Davidson JR, Feldman-Stewart D, Brennenstuhl S, Ram S (2007) How to provide insomnia interventions to people with cancer: insights from patients. Psychooncology 16(11):1028–1038PubMed

26.

Palesh O, Aldridge-Gerry A, Zeitzer JM, Koopman C, Neri E, Giese-Davis J, Jo B, Kraemer H, Nouriani B, Spiegel D (2014) Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep 37(5):837–842PubMedPubMedCentral

27.

Irwin M, McClintick J, Costlow C, Fortner M, White J, Gillin JC (1996) Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. FASEB J 10(5):643–653PubMed

28.

Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D (2000) Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92(12):994–1000PubMed

29.

Kidwell KM, Harte SE, Hayes DF, Storniolo AM, Carpenter J, Flockhart DA, Stearns V, Clauw DJ, Williams DA, Henry NL (2014) Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy. Cancer 120(16):2403–2411PubMedPubMedCentral

30.

Kakizaki M, Kuriyama S, Sone T, Ohmori-Matsuda K, Hozawa A, Nakaya N, Fukudo S, Tsuji I (2008) Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study. Br J Cancer 99(9):1502–1505PubMedPubMedCentral

31.

McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM (2006) Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res 15(3):241–249PubMed

32.

Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP, Yu MC (2008) Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29(6):1244–1248PubMedPubMedCentral

33.

Thompson CL, Li L (2012) Association of sleep duration and breast cancer OncotypeDX recurrence score. Breast Cancer Res Treat 134(3):1291–1295PubMedPubMedCentral

34.

Wang Y, Zhu X, Li L, Yi J, He J (2016) What factors affect the insomnia symptom trajectories in women with nonmetastatic breast cancer? J Pain Symptom Manag 52(6):850–858

35.

Mcdonough A, Lei Y, Hagget D, Jimenez RB, Johnston K, Moy B, Spring L, Peppercorn J (2019) Implementation of a brief screening tool to identify needs of cancer survivors. J Clin Oncol. https://doi.org/10.1200/JCO.2019.37.15_suppl.e23075 CrossRefPubMed

36.

Savard MH, Savard J, Simard S, Ivers H (2005) Empirical validation of the insomnia severity index in cancer patients. Psycho-Oncology 14(6):429–441PubMed

37.

Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A (2004) Psychometric evaluation of the pittsburgh sleep quality index in cancer patients. J Pain Symptom Manag 27(2):140–148

38.

Luyster FS, Choi J, Yeh CH, Imes CC, Johansson AE, Chasens ER (2015) Screening and evaluation tools for sleep disorders in older adults. Appl Nurs Res 28(4):334–340PubMedPubMedCentral

39.

Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein KL, Morin CM (2012) The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep 35(2):287–302PubMedPubMedCentral

40.

Edinger JD, Hoelscher TJ, Webb MD, Marsh GR, Radtke RA, Erwin CW (1989) Polysomnographic assessment of DIMS: empirical evaluation of its diagnostic value. Sleep 12(4):315–322PubMed

41.

Kupfer DJ, Reynolds CF 3rd (1997) Management of insomnia. N Engl J Med 336(5):341–346PubMed

42.

Vincent N, Lionberg C (2001) Treatment preference and patient satisfaction in chronic insomnia. Sleep 24(4):411–417PubMed

43.

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD (2016) Clinical guidelines committee of the American College of P: management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med 165(2):125–133PubMed

44.

Morin CM, Culbert JP, Schwartz SM (1994) Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 151(8):1172–1180PubMed

45.

Matthews EE, Berger AM, Schmiege SJ, Cook PF, McCarthy MS, Moore CM, Aloia MS (2014) Cognitive behavioral therapy for insomnia outcomes in women after primary breast cancer treatment: a randomized, controlled trial. Oncol Nurs Forum 41(3):241–253PubMed

46.

Dirksen SR, Epstein DR (2008) Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs 61(6):664–675PubMed

47.

Arnedt JT, Cuddihy L, Swanson LM, Pickett S, Aikens J, Chervin RD (2013) Randomized controlled trial of telephone-delivered cognitive behavioral therapy for chronic insomnia. Sleep 36(3):353–362PubMedPubMedCentral

48.

Dozeman E, Verdonck-de Leeuw IM, Savard J, van Straten A (2017) Guided web-based intervention for insomnia targeting breast cancer patients: feasibility and effect. Internet Interv 9:1–6PubMedPubMedCentral

49.

Atema V, van Leeuwen M, Kieffer JM, Oldenburg HSA, van Beurden M, Gerritsma MA, Kuenen MA, Plaisier PW, Lopes Cardozo AMF, van Riet YEA et al (2019) Efficacy of internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Clin Oncol 37(10):809–822PubMed

50.

Savard J, Ivers H, Savard MH, Morin CM (2016) Long-term effects of two formats of cognitive behavioral therapy for insomnia comorbid with breast cancer. Sleep 39(4):813–823PubMedPubMedCentral

51.

Vargas S, Antoni MH, Carver CS, Lechner SC, Wohlgemuth W, Llabre M, Blomberg BB, Gluck S, DerHagopian RP (2014) Sleep quality and fatigue after a stress management intervention for women with early-stage breast cancer in southern Florida. Int J Behav Med 21(6):971–981PubMedPubMedCentral

52.

Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS (2014) Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol 32(5):449–457PubMed

53.

Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, Widen RH, Fitzgerald SG, Shelton MM, Barta M et al (2009) Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho-Oncology 18(12):1261–1272PubMed

54.

Nakamura Y, Lipschitz DL, Kuhn R, Kinney AY, Donaldson GW (2013) Investigating efficacy of two brief mind-body intervention programs for managing sleep disturbance in cancer survivors: a pilot randomized controlled trial. J Cancer Surviv 7(2):165–182PubMedPubMedCentral

55.

Payne JK, Held J, Thorpe J, Shaw H (2008) Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum 35(4):635–642PubMed

56.

Rogers LQ, Fogleman A, Trammell R, Hopkins-Price P, Vicari S, Rao K, Edson B, Verhulst S, Courneya KS, Hoelzer K (2013) Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial. Integr Cancer Ther 12(4):323–335PubMed

57.

Mustian KM, Sprod LK, Janelsins M, Peppone LJ, Palesh OG, Chandwani K, Reddy PS, Melnik MK, Heckler C, Morrow GR (2013) Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol 31(26):3233–3241PubMedPubMedCentral

58.

Huang MI, Nir Y, Chen B, Schnyer R, Manber R (2006) A randomized controlled pilot study of acupuncture for postmenopausal hot flashes: effect on nocturnal hot flashes and sleep quality. Fertil Steril 86(3):700–710PubMed

59.

Guo J, Wang LP, Liu CZ, Zhang J, Wang GL, Yi JH, Cheng JL (2013) Efficacy of acupuncture for primary insomnia: a randomized controlled clinical trial. Evid Based Complement Alternat Med 2013:163850PubMedPubMedCentral

60.

Koffel E, Bramoweth AD, Ulmer CS (2018) Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review. J Gen Intern Med 33(6):955–962PubMedPubMedCentral

61.

Online Options for Insomnia Therapy [https://www.sleepreviewmag.com/sleep-treatments/behavioral-sleep-medicine/cognitive-behavioral-therapy/online-options-insomnia-therapy/]. Accessed 1 Apr 2020

62.

Morin CM, Koetter U, Bastien C, Ware JC, Wooten V (2005) Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. Sleep 28(11):1465–1471PubMed

63.

Chen WY, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, Schernhammer ES (2014) A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat 145(2):381–388PubMedPubMedCentral

64.

Holbrook AM, Crowther R, Lotter A, Cheng C, King D (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162(2):225–233PubMedPubMedCentral

65.

Buysse DJ (2013) Insomnia. JAMA 309(7):706–716PubMedPubMedCentral

66.

Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN (2012) Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the food and drug administration. BMJ 345:e8343PubMedPubMedCentral

67.

Yi XY, Ni SF, Ghadami MR, Meng HQ, Chen MY, Kuang L, Zhang YQ, Zhang L, Zhou XY (2018) Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med 45:25–32PubMed

68.

Belendiuk KA, Babson KA, Vandrey R, Bonn-Miller MO (2015) Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. Addict Behav 50:178–181PubMed

69.

Kuhathasan N, Dufort A, MacKillop J, Gottschalk R, Minuzzi L, Frey BN (2019) The use of cannabinoids for sleep: A critical review on clinical trials. Exp Clin Psychopharmacol 27(4):383–401PubMed

70.

Babson KA, Sottile J, Morabito D (2017) Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep 19(4):23PubMed

Titel: Evaluation and management of insomnia in women with breast cancer
verfasst von: Agnes Kwak
Jamie Jacobs
Dana Haggett
Rachel Jimenez
Jeffrey Peppercorn
Publikationsdatum: 20.04.2020
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 2/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-020-05635-0

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Evaluation and management of insomnia in women with breast cancer

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Association of body composition with function in women with early breast cancer

Complete pathologic response rate to neoadjuvant chemotherapy increases with increasing HER2/CEP17 ratio in HER2 overexpressing breast cancer: analysis of the National Cancer Database (NCDB)

External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients

Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women

Mechanistic basis for PI3K inhibitor antitumor activity and adverse reactions in advanced breast cancer

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie